UTHR UNITED THERAPEUTICS Corp
Price Chart
Executive Summary
Three UTHR insiders including the CEO, CFO, and EVP & General Counsel executed a series of option exercises and small open-market sales (total ~$331K) over May 18-21, 2026. The aggregate dollar value is negligible relative to the $24.0B market cap (~0.0014%), and the trades follow a pattern of near-simultaneous multi-leg option exercises with de minimis share sales — consistent with routine tax-withholding or cashless-exercise settlements, not informed selling.
Key Financial Metrics
Actionable Insight
These sales are routine tax-motivated transactions and carry no informational signal. UTHR has strong analyst sentiment and no material insider selling signal. Monitor the next earnings release and any change in the ongoing share buyback or pipeline developments for directional cues.
Key Facts
- Three insiders — CEO Martine A. Rothblatt, CFO James Edgemond, and EVP Paul A. Mahon — sold a combined ~$331K of shares on the open market.
- Sales are tiny relative to market cap (0.0014% of $24.0B), below the 0.1% threshold for materiality.
- Every sale is paired with a simultaneous derivative exercise (option exercise at $0 to $146.03), indicating a tax-withholding or cashless exercise pattern.
- All sales occurred within a 4-day window (May 18-21), consistent with a blackout-window opening post-earnings.
- The common stock has been strong, with analyst consensus 77% bullish and a prior cluster of sells totaling the same $331K noted in the 30d snapshot — this appears to be a recurring quarterly pattern.
Financial Impact
Total insider sales of ~$331K, representing 0.0014% of the $24.0B market cap — economically trivial.
Risk Factors
- No material risk indicated from this insider activity
- The $24B market cap with 77% bullish consensus already prices in continued execution risk on the PAH (pulmonary arterial hypertension) portfolio and potential generic competition for Remodulin/Tyvaso.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1779484617555 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 10, 2026
2d ago
|
Insider Cluster
| $544.59 awaiting T+1 | awaiting T+1 | — | $545.96 (+0.25%) |
|
Jun 9, 2026
3d ago
|
Insider Cluster
| $553.04 awaiting T+1 | awaiting T+1 | — | $545.96 (−1.28%) |
|
Jun 5, 2026
7d ago
|
Insider Cluster
| $547.10 awaiting T+1 | awaiting T+1 | — | $545.96 (−0.21%) |
|
Jun 4, 2026
8d ago
|
Insider Cluster
| $547.10 awaiting T+1 | awaiting T+1 | — | $545.96 (−0.21%) |
|
Jun 4, 2026
8d ago
|
Insider Cluster
| $547.10 awaiting T+1 | awaiting T+1 | — | $545.96 (−0.21%) |
|
Jun 3, 2026
9d ago
|
Insider Cluster
| $547.22 $546.37 | ▼ −0.16% | ▲ +2.44% | $545.96 (−0.23%) |
|
May 29, 2026
14d ago
|
Insider Cluster
| $544.45 $539.91 | ▼ −0.83% | ▼ −0.98% | $545.96 (+0.28%) |
|
May 28, 2026
15d ago
|
Insider Cluster
| $553.34 $544.45 | ▼ −1.61% | ▼ −1.86% | $545.96 (−1.33%) |
|
May 27, 2026
16d ago
|
Insider Cluster
| $561.70 $553.34 | ▼ −1.49% | ▼ −1.73% | $545.96 (−2.80%) |
|
May 26, 2026
17d ago
|
Insider Cluster
| $567.74 $561.70 | ▼ −1.06% | ▼ −1.62% | $545.96 (−3.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access